This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091
An Open Label Phase I PET Imaging Study to Investigate the Bio-distribution and Tumor Uptake of [89Zr]Zr-BI 754111 in Patients With Advanced Non-small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma Treated With BI 754111 in Combination With BI 754091
Sponsor: Boehringer Ingelheim
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Boehringer Ingelheim
Other Carcinoma, Non-Small-Cell Lung trials with similar outcome
Listed as NCT03780725, this PHASE1 trial focuses on Carcinoma, Non-Small-Cell Lung and Head and Neck Neoplasms and remains terminated or withdrawn. Sponsored by Boehringer Ingelheim, it has been updated 31 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
31 versions recorded-
Feb 2026 — Present [monthly]
Terminated PHASE1
-
Sep 2024 — Feb 2026 [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Oct 2021 — Dec 2021 [monthly]
Terminated PHASE1
Status: Completed → Terminated
▶ Show 26 earlier versions
-
Mar 2021 — Oct 2021 [monthly]
Completed PHASE1
-
Jan 2021 — Mar 2021 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Nov 2020 — Dec 2020 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting PHASE1
-
Sep 2020 — Oct 2020 [monthly]
Recruiting PHASE1
-
Aug 2020 — Sep 2020 [monthly]
Recruiting PHASE1
-
Jul 2020 — Aug 2020 [monthly]
Recruiting PHASE1
Status: Suspended → Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Suspended PHASE1
-
May 2020 — Jun 2020 [monthly]
Suspended PHASE1
Status: Recruiting → Suspended
-
Apr 2020 — May 2020 [monthly]
Recruiting PHASE1
-
Mar 2020 — Apr 2020 [monthly]
Recruiting PHASE1
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE1
-
Jan 2020 — Feb 2020 [monthly]
Recruiting PHASE1
-
Dec 2019 — Jan 2020 [monthly]
Recruiting PHASE1
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE1
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE1
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE1
-
Aug 2019 — Sep 2019 [monthly]
Recruiting PHASE1
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE1
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE1
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE1
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE1
-
Mar 2019 — Apr 2019 [monthly]
Recruiting PHASE1
-
Feb 2019 — Mar 2019 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jan 2019 — Feb 2019 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Boehringer Ingelheim
For direct contact, visit the study record on ClinicalTrials.gov .